Trial intelligence / Profile preview

Propofol vs Sevoflurane for Recovery After Anal Fistula Surgery in Obese Patients

NCT05529875Withdrawn

Start
Oct 2022
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of propofol injection (veterinary) and sevoflurane in anal fistula (2 arms). Primary endpoint: Quality of Recovery-40 at 48 hours. Planned start Oct 2022; status: withdrawn.

02

Drugs

propofol injection (veterinary)sevoflurane
03

Conditions

anal fistula

Beyond the preview

Go deeper on NCT05529875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05529875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call